Advanced Enzyme [ADVENZYMES] vs Tanfac Industries [TANFACIND] Detailed Stock Comparison

Advanced Enzyme
NSE
Loading...

Tanfac Industries
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Advanced Enzyme wins in 12 metrics, Tanfac Industries wins in 8 metrics, with 0 ties. Advanced Enzyme appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Advanced Enzyme | Tanfac Industries | Better |
---|---|---|---|
P/E Ratio (TTM) | 25.13 | 48.54 | Advanced Enzyme |
Price-to-Book Ratio | 2.42 | 14.95 | Advanced Enzyme |
Debt-to-Equity Ratio | 2.68 | 13.28 | Advanced Enzyme |
PEG Ratio | 1.47 | 0.68 | Tanfac Industries |
EV/EBITDA | 15.56 | 36.16 | Advanced Enzyme |
Profit Margin (TTM) | 20.48% | 15.83% | Advanced Enzyme |
Operating Margin (TTM) | 25.18% | 18.58% | Advanced Enzyme |
EBITDA Margin (TTM) | 25.18% | 18.58% | Advanced Enzyme |
Return on Equity | 8.93% | 32.50% | Tanfac Industries |
Return on Assets (TTM) | 8.09% | 20.35% | Tanfac Industries |
Free Cash Flow (TTM) | $1.08B | $-641.87M | Advanced Enzyme |
Dividend Yield | 1.56% | 0.20% | Advanced Enzyme |
1-Year Return | -28.36% | 118.40% | Tanfac Industries |
Price-to-Sales Ratio (TTM) | 5.14 | 8.37 | Advanced Enzyme |
Enterprise Value | $29.31B | $46.60B | Tanfac Industries |
EV/Revenue Ratio | 4.39 | 8.37 | Advanced Enzyme |
Gross Profit Margin (TTM) | 73.08% | 38.17% | Advanced Enzyme |
Revenue per Share (TTM) | $60 | $558 | Tanfac Industries |
Earnings per Share (Diluted) | $12.22 | $96.29 | Tanfac Industries |
Beta (Stock Volatility) | 0.37 | -0.21 | Tanfac Industries |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Advanced Enzyme vs Tanfac Industries Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Advanced Enzyme | 0.65% | -1.60% | -4.70% | 7.21% | -0.50% | -12.42% |
Tanfac Industries | -4.13% | 14.37% | 1.73% | 42.87% | 38.82% | 52.67% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Advanced Enzyme | -28.36% | 15.08% | 30.43% | 7.83% | 7.83% | 7.83% |
Tanfac Industries | 118.40% | 799.87% | 2,165.80% | 10,439.68% | 16,866.79% | 6,577.64% |
Performance & Financial Health Analysis: Advanced Enzyme vs Tanfac Industries
Metric | ADVENZYMES | TANFACIND |
---|---|---|
Market Information | ||
Market Cap | ₹34.36B | ₹46.63B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 666,128 | 9,296 |
90 Day Avg. Volume | 479,369 | 17,249 |
Last Close | ₹309.10 | ₹4,481.10 |
52 Week Range | ₹257.90 - ₹571.00 | ₹1,890.00 - ₹4,961.40 |
% from 52W High | -45.87% | -9.68% |
All-Time High | ₹571.00 (Sep 16, 2024) | ₹4,961.40 (Jul 17, 2025) |
% from All-Time High | -45.87% | -9.68% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.20% | 0.67% |
Quarterly Earnings Growth | 0.17% | 0.80% |
Financial Health | ||
Profit Margin (TTM) | 0.20% | 0.16% |
Operating Margin (TTM) | 0.25% | 0.19% |
Return on Equity (TTM) | 0.09% | 0.33% |
Debt to Equity (MRQ) | 2.68 | 13.28 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹127.00 | ₹312.69 |
Cash per Share (MRQ) | ₹52.94 | ₹44.96 |
Operating Cash Flow (TTM) | ₹1.70B | ₹328.42M |
Levered Free Cash Flow (TTM) | ₹1.31B | ₹-860,044,864 |
Dividends | ||
Last 12-Month Dividend Yield | 1.56% | 0.20% |
Last 12-Month Dividend | ₹5.20 | ₹7.00 |
Valuation & Enterprise Metrics Analysis: Advanced Enzyme vs Tanfac Industries
Metric | ADVENZYMES | TANFACIND |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 25.13 | 48.54 |
Forward P/E | 24.67 | N/A |
PEG Ratio | 1.47 | 0.68 |
Price to Sales (TTM) | 5.14 | 8.37 |
Price to Book (MRQ) | 2.42 | 14.95 |
Market Capitalization | ||
Market Capitalization | ₹34.36B | ₹46.63B |
Enterprise Value | ₹29.31B | ₹46.60B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.39 | 8.37 |
Enterprise to EBITDA | 15.56 | 36.16 |
Risk & Other Metrics | ||
Beta | 0.37 | -0.21 |
Book Value per Share (MRQ) | ₹127.00 | ₹312.69 |
Financial Statements Comparison: Advanced Enzyme vs Tanfac Industries
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ADVENZYMES | TANFACIND |
---|---|---|
Revenue/Sales | ₹1.86B | ₹1.72B |
Cost of Goods Sold | ₹500.49M | ₹997.76M |
Gross Profit | ₹1.36B | ₹721.74M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹468.14M | ₹319.53M |
EBITDA | ₹652.82M | ₹364.73M |
Pre-Tax Income | ₹549.00M | ₹311.96M |
Income Tax | ₹144.60M | ₹84.58M |
Net Income (Profit) | ₹404.40M | ₹227.38M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ADVENZYMES | TANFACIND |
---|---|---|
Cash & Equivalents | ₹942.25M | ₹301.18M |
Total Current Assets | ₹8.80B | ₹2.46B |
Total Current Liabilities | ₹967.55M | ₹1.08B |
Long-Term Debt | ₹209.17M | N/A |
Total Shareholders Equity | ₹14.69B | ₹3.12B |
Retained Earnings | ₹11.53B | N/A |
Property, Plant & Equipment | ₹2.93B | ₹1.68B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ADVENZYMES | TANFACIND |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ADVENZYMES | TANFACIND |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 666,128 | 9,296 |
Average Daily Volume (90 Day) | 479,369 | 17,249 |
Shares Outstanding | 111.88M | 9.98M |
Float Shares | 29.32M | 3.57M |
% Held by Insiders | 0.56% | 0.75% |
% Held by Institutions | 0.21% | 0.00% |
Dividend Analysis & Yield Comparison: Advanced Enzyme vs Tanfac Industries
Metric | ADVENZYMES | TANFACIND |
---|---|---|
Last 12-Month Dividend | ₹5.20 | ₹7.00 |
Last 12-Month Dividend Yield | 1.56% | 0.20% |
3-Year Avg Annual Dividend | ₹5.43 | ₹6.33 |
3-Year Avg Dividend Yield | 0.75% | 0.47% |
3-Year Total Dividends | ₹16.30 | ₹19.00 |
Ex-Dividend Date | Jul 23, 2025 | Sep 20, 2024 |